European Cannabis Company EMMAC Life Sciences To Go Public On Nasdaq

EMMAC Life Sciences, one of Europe’s largest cannabis companies, announced its plans to go public in the U.S.

It will list on the Nasdaq exchange through a merger with Andina Acquisition Corp. III (NASDAQ: ANDA) (NASDAQ: ANDAW) (NASDAQ: ANDAU). 

EMMAC shareholders expect to collectively own a majority stake in the combined public company. EMMAC’s Chairman Lorne Abony, CEO Antonio Costanzo, CFO Thomas Ellen, and COO Tom Rooke, will continue to …

Full story available on Benzinga.com

More European Cannabis Company EMMAC Life Sciences To Go Public On Nasdaq